Market Cap 338.84M
Revenue (ttm) 0.00
Net Income (ttm) 1.44M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 243,600
Avg Vol 131,422
Day's Range N/A - N/A
Shares Out 43.27M
Stochastic %K 79%
Beta -0.31
Analysts Hold
Price Target $7.25

Company Profile

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of negative symptoms in patients with schizophrenia. The company also has exclusive rights to develop and commercialize MIN-301, a soluble recombinant form of the Neuregulin-1b1 protein for the treatment of Parkinson's disease and other neur...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 600 7373
Address:
1500 District Avenue, Burlington, United States
erevnon
erevnon Mar. 12 at 11:40 AM
HC Wainwright & Co. maintains Minerva Neurosciences $NERV at Neutral and raises the price target from $4 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
FilingTracker
FilingTracker Mar. 11 at 1:29 PM
$NERV Offering - up to $200 million: https://www.sec.gov/Archives/edgar/data/1598646/000119312526101196/d71904ds3.htm
0 · Reply
AnalyticalOne
AnalyticalOne Mar. 11 at 12:27 PM
$NERV exceeded earnings and revenue so what exactly is the bear case here?
0 · Reply
StockNews_Live
StockNews_Live Mar. 11 at 11:01 AM
$NERV 🎯 STOCK NEWS ALERT 💵 Price: $7.89 (-0.75%) 🔥 Sentiment Score: 85/100 🚀 VERY POSITIVE NEWS 📄 Minerva Neurosciences, Inc. provided business updates and reported financial results for the fourth quarter and year ended December 31, 2025. The company initiated a confirmatory Phase 3 trial with… 📎 https://stocknews.live/news/NERV/minerva-neurosciences-reports-fourth-53098.html
0 · Reply
Invest2Create
Invest2Create Mar. 11 at 5:14 AM
Having looked up the fundamental facts on $ASNS, its technicals look even better. Making a one-day, close-to-close 186.56% upswing on March 4, Atcelis Networks is currently holding a support level of 0.32, a 77% retracement from the March 4 high of 0.73, just above the Fibonacci retracement level of 78.6%. This mirrors “First Step” setups, as I call them, that: • $AGMH made September 8-18 • $BBGI made November 21 - December 9 and • $NERV made October 8-20 before each of those stocks made parabolic moves upward. It’s of course not a guarantee $ASNS will go up like these other stocks have, anymore than this post is anything more than considered analysis and opinion but not investment advice. But, taking these other stocks into account, $ASNS’ current setup is looking
0 · Reply
Stock_Catcher
Stock_Catcher Mar. 10 at 2:16 AM
Treasure Tuesday Watchlist Pt. 5 $IBRX $RLMD $GSIW $HIMS $NERV Let's Find Another Supernova Tomorrow
0 · Reply
Invest2live
Invest2live Mar. 9 at 7:29 PM
$NERV 235% already; get in $HUMA and $AKBA after your DD.
0 · Reply
topstockalerts
topstockalerts Mar. 9 at 7:19 PM
$NERV biotech that previously moved on drug development updates and restructuring plans. These setups can reawaken when traders anticipate new clinical catalysts or funding clarity. Does speculation return?
0 · Reply
JonathanV
JonathanV Mar. 9 at 5:02 PM
$NERV why?
0 · Reply
Elaine_Shrimp
Elaine_Shrimp Mar. 9 at 4:58 PM
$NERV now is distributing stage
0 · Reply
Latest News on NERV
Minerva Neurosciences: There's Probably Time For One More Rally

Aug 23, 2023, 4:05 AM EDT - 2 years ago

Minerva Neurosciences: There's Probably Time For One More Rally


erevnon
erevnon Mar. 12 at 11:40 AM
HC Wainwright & Co. maintains Minerva Neurosciences $NERV at Neutral and raises the price target from $4 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
FilingTracker
FilingTracker Mar. 11 at 1:29 PM
$NERV Offering - up to $200 million: https://www.sec.gov/Archives/edgar/data/1598646/000119312526101196/d71904ds3.htm
0 · Reply
AnalyticalOne
AnalyticalOne Mar. 11 at 12:27 PM
$NERV exceeded earnings and revenue so what exactly is the bear case here?
0 · Reply
StockNews_Live
StockNews_Live Mar. 11 at 11:01 AM
$NERV 🎯 STOCK NEWS ALERT 💵 Price: $7.89 (-0.75%) 🔥 Sentiment Score: 85/100 🚀 VERY POSITIVE NEWS 📄 Minerva Neurosciences, Inc. provided business updates and reported financial results for the fourth quarter and year ended December 31, 2025. The company initiated a confirmatory Phase 3 trial with… 📎 https://stocknews.live/news/NERV/minerva-neurosciences-reports-fourth-53098.html
0 · Reply
Invest2Create
Invest2Create Mar. 11 at 5:14 AM
Having looked up the fundamental facts on $ASNS, its technicals look even better. Making a one-day, close-to-close 186.56% upswing on March 4, Atcelis Networks is currently holding a support level of 0.32, a 77% retracement from the March 4 high of 0.73, just above the Fibonacci retracement level of 78.6%. This mirrors “First Step” setups, as I call them, that: • $AGMH made September 8-18 • $BBGI made November 21 - December 9 and • $NERV made October 8-20 before each of those stocks made parabolic moves upward. It’s of course not a guarantee $ASNS will go up like these other stocks have, anymore than this post is anything more than considered analysis and opinion but not investment advice. But, taking these other stocks into account, $ASNS’ current setup is looking
0 · Reply
Stock_Catcher
Stock_Catcher Mar. 10 at 2:16 AM
Treasure Tuesday Watchlist Pt. 5 $IBRX $RLMD $GSIW $HIMS $NERV Let's Find Another Supernova Tomorrow
0 · Reply
Invest2live
Invest2live Mar. 9 at 7:29 PM
$NERV 235% already; get in $HUMA and $AKBA after your DD.
0 · Reply
topstockalerts
topstockalerts Mar. 9 at 7:19 PM
$NERV biotech that previously moved on drug development updates and restructuring plans. These setups can reawaken when traders anticipate new clinical catalysts or funding clarity. Does speculation return?
0 · Reply
JonathanV
JonathanV Mar. 9 at 5:02 PM
$NERV why?
0 · Reply
Elaine_Shrimp
Elaine_Shrimp Mar. 9 at 4:58 PM
$NERV now is distributing stage
0 · Reply
Mg_1970
Mg_1970 Mar. 9 at 4:34 PM
$NERV 😱😍😍😎
0 · Reply
topstockalerts
topstockalerts Mar. 9 at 3:42 PM
$NERV Following this closely as it continues to build momentum. Buyers are in control. Could be more upside ahead.
0 · Reply
Stock_Catcher
Stock_Catcher Mar. 9 at 2:21 PM
$NERV thin one hitting my scanner
0 · Reply
Elaine_Shrimp
Elaine_Shrimp Mar. 9 at 2:05 PM
$NERV .🤫
0 · Reply
BillionerOfKing
BillionerOfKing Mar. 4 at 7:36 PM
$NERV Current Stock Price: $6.81
0 · Reply
kshonstocks
kshonstocks Mar. 2 at 6:17 PM
$NERV terrific ibd-99 A https://research.investors.com/stock-quotes/nasdaq-minerva-neurosciences-nerv.htm $NERV
0 · Reply
kshonstocks
kshonstocks Mar. 2 at 5:53 PM
like this $NERV chart and action
0 · Reply
AshMomentum
AshMomentum Feb. 18 at 7:02 AM
$NERV Minerva Neurosciences develops CNS therapies, facing clinical-stage pipeline with high failure risk and binary catalysts [citation:historical].
0 · Reply
6GodEnergy
6GodEnergy Feb. 17 at 6:29 PM
0 · Reply
6GodEnergy
6GodEnergy Feb. 17 at 4:12 PM
0 · Reply
S2K_TP
S2K_TP Feb. 11 at 4:45 AM
$NERV on watch
0 · Reply
VolArbTrader
VolArbTrader Feb. 11 at 4:24 AM
$NERV Neuroscience-focused biotech; CNS drug development carries exceptionally high failure rates and long trial timelines, making valuation highly sensitive to clinical readouts.
0 · Reply